Manu Ohri

Manu Ohri is a declared insider at 2 companies; the most frequent names are GT Biopharma, Inc. and Axil Brands, Inc. Between 15 July 2022 and 15 January 2026, the trades on record add up to 10 filings.

On the market, this insider has only ever bought: 1 purchase, €23k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants.

Most recently, on 4 March 2026, the filings show a share grant in Axil Brands, Inc. The latest purchase dates back some time: it was published 1,293 days ago, on 10 April 2023. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.